Continuing Medical Education: HAART CME: HIV Minifellowship: Current Challenges in the Clinical Management of HAART: ABcomm, Inc.:Orlando, FL: Course CME: October 18, 2008
- By ABcomm, Inc.
- Published 09/14/2008
- Public Health , Primary Care , Osteopathy , Multi-Speciality , Internal Medicine , Infectious Disease , Immunology , General Medicine , Family Medicine
- Unrated
HIV Minifellowship: Current Challenges in the Clinical Management of HAART
ABcomm, Inc.
ABcomm, Inc., with headquarters in Champaign, Illinois and Scottsdale, Arizona, has been involved in developing continuing education and training programs for health professionals since 1988.
Our primary focus is on accredited activities for physicians, pharmacists and nurse practitioners. ABcomm, Inc. is accredited by the American Council for Continuing Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Academy of Nurse Practitioners (AANP).
View All Postings by This Contributor.
CME Sponsor: ABcomm, Inc.
Course Directors/Instructors:
Edwin DeJesus, MD
Registration Fee: $30
Number of credits:
5.5 AMA PRA Category 1 Credits™
Registration:
By Fax: Fax
completed form to ABcomm at (217) 355 – 1469
By Phone:
Call ABcomm at (800) 451 - 4068
Detailed Description:
This half-day minifellowship is designed to provide physicians with evidence-based information on current issues and management strategies in the treatment of HIV/AIDS. Through a live patient interview, lectures, case studies and open discussions, the small group format facilitates interaction between attendees and local and national opinion leaders.
The goal of this Minifellowship is to enhance the knowledge of providers resulting in improved patient care. Topics have been selected based on extensive needs assessment data in the treatment of HIV/AIDS, including past participant surveys, clinical expert input, and practice guideline reviews.
- Discuss significant developments in the clinical course and management of
HIV/AIDS with special focus on
antiretroviral therapy treatment regimens.
- Describe recent antiretroviral toxicity, resistance, drug interaction and
side effect data, and strategies for management.
- Consider the impact of hepatitis co-infections and describe the most
recent hepatitis treatment strategies.
- Demonstrate knowledge of the variable effects on insulin resistance,
diabetes, and cardiovascular risks associated with different classes of
antiretroviral therapy.
- Describe the physical and psychological impact of HAART related lipodystrophy on long-term patient compliance to treatment.
Spread The Word
This review is the subjective opinion of a CME Networks site member or user and not of CME Networks, LLC.
CMENetworks.com Comment Policy: CMEnetworks.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene or other material that would violate the law. Please note that CMEnetworks.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors or commentors. By submitting your comment, you hereby give CMEnetworks.com the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now know or hereafter devised, worldwide, in perpetuity.
